The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Novo Nordisk A/SEU/1/20/1430/008-010

Main Information

Trade NameRybelsus
Active SubstancesSemaglutide
Dosage FormTablet
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/20/1430/008-010

Group Information

ATC CodeA10BJ06 semaglutide


License statusAuthorised
Licence Issued03/04/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back